# Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report

## TL;DR

A 33-year-old man developed spinal cord infarction after a liver cancer treatment, showing the rare but serious neurological risks of this procedure.

## Contribution

Reports a rare case of spinal cord infarction following transarterial chemoembolization for hepatocellular carcinoma.

## Key findings

- A patient developed acute paraplegia after undergoing transarterial chemoembolization.
- The patient showed partial neurological recovery with corticosteroid treatment and supportive care.
- The case emphasizes the need to consider extrahepatic arterial supply during the procedure.

## Abstract

Spinal cord infarction is a rare but serious complication following transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). We report a case of a 33-year-old male with a history of chronic hepatitis B and multiple prior TACE sessions who developed acute paraplegia after undergoing another TACE procedure. With immediate administration of high-dose corticosteroids and supportive care, the patient had partial neurological recovery. This case highlights the importance of recognizing extrahepatic arterial supply and the potential neurological risks associated with TACE.